(S (NP-SBJ-7 (NP (NN Activity)) (PP (IN of) (NP (NP (DT the) (NN kappa) (NN B) (NN enhancer)) (PP (IN of) (NP (DT the) (NN interleukin-2) (NN receptor) (NN alpha) (NN chain))))) (PP (IN in) (NP (JJ somatic) (NN cell) (NNS hybrids)))) (VP (VBZ is) (VP (VBN accompanied) (NP (-NONE- *-7)) (PP (IN by) (NP-LGS (NP (DT the) (JJ nuclear) (NN localization)) (PP (IN of) (NP (NN NF-kappa) (NN B))))))) (. .))
(S (NP-SBJ-COOD-8 (NP (NP (DT The) (CD two) (JJ nuclear) (NNS proteins) (NN NF-kappa) (NN B)) (-LRB- -LRB-) (VP (VBG consisting) (PP (IN of) (NP (NNS subunits) (NP-COOD (NP (NN p50)) (CC and) (NP (NN p65)))))) (-RRB- -RRB-)) (CC and) (NP (NP (NP (DT the) (JJ DNA-binding) (NN subunit)) (PP (IN of) (NP (NP (NN NF-kappa) (NN B)) (PRN (-LRB- -LRB-) (NP (NN p50)) (-RRB- -RRB-)))) (PP (IN by) (NP (PRP itself)))) (, ,) (VP (ADVP (RB also)) (VBN called) (S (NP-SBJ (-NONE- *)) (NP-PRD (NN KBF1))))) (, ,)) (VP (VBP are) (ADVP (RB constitutively)) (VP (VP-COOD (VP (VBN expressed) (NP-9 (-NONE- *-8))) (CC and) (VP (JJ localized) (NP (-NONE- *-9)))) (PP (IN in) (NP (DT the) (NN nucleus)) (PP (IN of) (NP (DT the) (JJ human) (NN T-cell) (NN line) (NN IARC) (CD 301.5)))))) (. .))
(S (SBAR-ADV (IN In) (NN order) (TO to) (S (NP-SBJ (-NONE- *-10)) (VP (VB define) (NP (NP (DT the) (NNS roles)) (PP (IN of) (NP (NP (DT these) (CD two) (NNS factors)) (, ,) (SBAR (WHNP-11 (WDT which)) (S (NP-SBJ (-NONE- *T*-11)) (VP (VBP bind) (PP (TO to) (NP (DT the) (JJ same) (NN kappa) (NN B) (NNS enhancers)))))))))))) (, ,) (PP (IN in) (NP (NN transcription) (NN activation))) (NP-SBJ-10 (PRP we)) (VP (VBP have) (VP (VBN prepared) (NP (NP (JJ somatic) (NN cell) (NNS hybrids)) (PP (IN between) (NP-COOD (NP (NN IARC) (CD 301.5)) (CC and) (NP (DT a) (JJ murine) (NN myeloma))))))) (. .))
(S-COOD (S (NP-SBJ (JJS Most) (NNS hybrids)) (VP (VBP express) (NP-COOD (CC both) (NP (NN KBF1)) (CC and) (NP (NN NF-kappa) (NN B))) (PP (IN in) (NP (PRP$ their) (NNS nuclei))))) (, ,) (CC but) (S (NP-SBJ (CD one) (NN hybrid)) (VP (VBZ expresses) (NP (RB only) (NN KBF1)))) (. .))
(S (NP-SBJ (NP (DT The) (NN kappa) (NN B) (NN enhancer)) (PP (IN of) (NP (NP (DT the) (NN gene)) (VP (VBG encoding) (NP (NP (DT the) (NP (NP (NN interleukin-2)) (PRN (-LRB- -LRB-) (NP (NN IL-2)) (-RRB- -RRB-))) (NN receptor) (NN alpha) (NN chain)) (PRN (-LRB- -LRB-) (NP (NN IL-2R) (NN alpha)) (-RRB- -RRB-))))))) (VP (VBZ is) (ADJP-PRD (JJ functional)) (PP (RB only) (IN in) (NP (NP (DT the) (NNS hybrids)) (VP (VBG expressing) (NP (JJ nuclear) (NN NF-kappa) (NN B)))))) (. .))
(S (NP-SBJ (DT These) (NNS findings)) (VP (VBP show) (SBAR (IN that) (S (NP-SBJ-12 (JJ nuclear) (NN NF-kappa) (NN B)) (VP (VBZ is) (ADJP-PRD (JJ necessary) (S (NP-SBJ (-NONE- *-12)) (VP (TO to) (VP (VB activate) (NP (DT the) (NN kappa) (NN B) (NN enhancer)))))) (, ,) (SBAR (IN while) (S (NP-SBJ (NP (NN KBF1)) (PP (IN by) (NP (PRP itself)))) (VP (VBZ is) (RB not) (ADJP-PRD (JJ sufficient))))))))) (. .))
(S (NP-SBJ (PRP We)) (VP-COOD (VP (VBP propose) (SBAR (IN that) (S (NP-SBJ (NN KBF1)) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ competitive) (NN inhibitor)) (PP (IN of) (NP (NN NF-kappa) (NN B)))))))) (CC and) (VP (VB discuss) (SBAR (WHADVP-13 (WRB how)) (S (NP-SBJ-14 (DT these) (NNS factors)) (VP (MD may) (VP (VB be) (VP (VBN involved) (NP (-NONE- *-14)) (PP (IN in) (NP (NP (DT the) (JJ transient) (NN expression)) (PP (IN of) (NP (NP-COOD (NP (NN IL-2)) (CC and) (NP (NN IL-2) (NN alpha))) (NNS genes))) (PP-TMP (IN during) (NP (DT the) (JJ immune) (NN response))))) (ADVP (-NONE- *T*-13))))))))) (. .))
